Coherus Oncology (CHRS) EBIT Margin (2013 - 2026)
Coherus Oncology's EBIT Margin was -225.98% in Q2 2026, up 217.61 percentage points from -443.59% a year earlier and up 67.69 percentage points from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) EBIT Margin (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Coherus Oncology's EBIT Margin was -311.56% through Jun 30, 2026, up 267.37 percentage points year-over-year; for FY2025, it was -429.51%, up 327.06 percentage points from FY2024.
- EBIT Margin shows a five-year change of -462.36 percentage points (FY2020 to FY2025).
- In earlier years, EBIT Margin was -756.58% in FY2024 (-677.59 pp), -78.99% in FY2023 (+42.73 pp), -121.72% in FY2022 (-40.92 pp) and -80.80% in FY2021 (-113.65 pp).
- The Q2 2026 figure marks the highest quarterly EBIT Margin since Q4 2023.
- Compared with a year earlier, EBIT Margin has increased for four straight quarters, with an average year-over-year change of +272.18 percentage points over the last eight quarters.
- The best year-over-year quarter for EBIT Margin over five years was Q1 2025 (a gain of 2339.14 percentage points); the worst was Q1 2024 (a drop of 2728.19 percentage points).
- Per Business Quant data, CHRS's EBIT Margin in the three quarters before Q2 2026 was -293.67% (Q1 2026), -359.90% (Q4 2025) and -383.14% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 28.37% |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | -225.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -225.98% |
| Mar 31, 2026 | -293.67% |
| Dec 31, 2025 | -359.90% |
| Sep 30, 2025 | -383.14% |
| Jun 30, 2025 | -443.59% |
| Mar 31, 2025 | -597.91% |
| Dec 31, 2024 | -586.89% |
| Sep 30, 2024 | -774.22% |
| Jun 30, 2024 | -384.87% |
| Mar 31, 2024 | -2,937.05% |
| Dec 31, 2023 | -75.29% |
| Sep 30, 2023 | -42.92% |
| Jun 30, 2023 | -58.83% |
| Mar 31, 2023 | -208.86% |
| Dec 31, 2022 | -113.54% |
| Sep 30, 2022 | -177.11% |
| Jun 30, 2022 | -73.17% |
| Mar 31, 2022 | -134.62% |
| Dec 31, 2021 | -53.91% |
| Sep 30, 2021 | -39.74% |
API Access
Coherus Oncology EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();